The Food and Drug Administration (FDA) has approved Restasis for treating chronic dry eye in adults and children ages 16 years and older. It’s available in single-use vials and a multiuse bottle.

Please provide your email address to receive an email when new articles are posted on . A water-free cyclosporine 0.1% solution showed efficacy in improving dry eye signs and symptoms. Tolerability, ...

VEVYE® is the First and Only Cyclosporine-Based Product Indicated for the Treatment of Both Signs and Symptoms of Dry Eye Disease with Efficacy Demonstrated After Four Weeks VEVYE® is the Only ...

Please provide your email address to receive an email when new articles are posted on . Cold instillation was associated with significantly lower discomfort compared with warm instillation. The relief ...

Presentation at the American Academy of Optometry (AAOPT) 2023 showed significant improvements with CEQUA ® for topical ophthalmic use in both corneal fluorescein staining (CFS) and symptom ...